Literature DB >> 19155474

CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches.

Zhongbin Bai1, Haruko Hayasaka, Masayoshi Kobayashi, Wenzhe Li, Zijin Guo, Myoung Ho Jang, Akihiro Kondo, Byung-il Choi, Yoichiro Iwakura, Masayuki Miyasaka.   

Abstract

A number of chemokines, including CCL21, CCL19, CXCL12, and CXCL13, are coexpressed on the lumen or basal lamina of high endothelial venules (HEVs) in lymph nodes (LNs) and Peyer's patches (PPs), consistent with the idea that they might cooperate to regulate lymphocyte trafficking into these lymphoid tissues. In this study we report that CXCL12, acting through its receptor, CXCR4, cooperates with CCR7 ligands to promote T cell trafficking across HEVs. CXCL12 enhanced the CCR7-induced chemotaxis of wild-type but not CXCR4-deficient T cells in vitro at suboptimal concentrations of a CCR7 ligand, but without affecting the expression level or ligand-binding ability of CCR7. Real-time chemotaxis analysis showed that CXCL12 substantially shortened the lag time before cell migration began in vitro, but not the migration speed of T cells responding to suboptimal CCR7 ligand concentrations. In addition, CXCL12 augmented the CCR7 ligand-driven ERK phosphorylation and actin polymerization in T cells under the same conditions. In adoptive transfer experiments, CXCL12 promoted naive T cell trafficking to LNs and PPs in wild-type but not CCR7 ligand-deficient plt/plt recipient mice; this increased T cell trafficking was associated with enhanced binding of the T cells to HEVs and their subsequent migration into the LN parenchyma. Thus, CXCL12 synergizes with CCR7 ligands to promote T cell migration by sensitizing T cells through CXCR4, thus enabling them to respond to lower concentrations of CCR7 ligands. Such concerted action of chemokines provides an additional, previously unknown mechanism for efficient lymphocyte trafficking across HEVs into LNs and PPs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155474     DOI: 10.4049/jimmunol.182.3.1287

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  An integrated stochastic model of "inside-out" integrin activation and selective T-lymphocyte recruitment.

Authors:  Michael T Beste; Dooyoung Lee; Michael R King; Gary A Koretzky; Daniel A Hammer
Journal:  Langmuir       Date:  2012-01-04       Impact factor: 3.882

2.  Crosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells.

Authors:  Jone Garay; June A D'Angelo; YongKeun Park; Christopher M Summa; Martha L Aiken; Eric Morales; Kamran Badizadegan; Edda Fiebiger; Bonny L Dickinson
Journal:  J Immunol       Date:  2010-08-20       Impact factor: 5.422

3.  Chemokine cooperativity is caused by competitive glycosaminoglycan binding.

Authors:  Guido J R Zaman; Martine J Smit; Folkert Verkaar; Jody van Offenbeek; Miranda M C van der Lee; Lambertus H C J van Lith; Anne O Watts; Angelique L W M M Rops; David C Aguilar; Joshua J Ziarek; Johan van der Vlag; Tracy M Handel; Brian F Volkman; Amanda E I Proudfoot; Henry F Vischer
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

4.  CRK proteins selectively regulate T cell migration into inflamed tissues.

Authors:  Yanping Huang; Fiona Clarke; Mobin Karimi; Nathan H Roy; Edward K Williamson; Mariko Okumura; Kazuhiro Mochizuki; Emily J H Chen; Tae-Ju Park; Gudrun F Debes; Yi Zhang; Tom Curran; Taku Kambayashi; Janis K Burkhardt
Journal:  J Clin Invest       Date:  2015-01-26       Impact factor: 14.808

5.  Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer.

Authors:  Alex B Blair; Victoria M Kim; Stephen T Muth; May Tun Saung; Nathalie Lokker; Barbara Blouw; Todd D Armstrong; Elizabeth M Jaffee; Takahiro Tsujikawa; Lisa M Coussens; Jin He; Richard A Burkhart; Christopher L Wolfgang; Lei Zheng
Journal:  Clin Cancer Res       Date:  2019-06-11       Impact factor: 12.531

6.  Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis.

Authors:  L Longobardi; J D Temple; L Tagliafierro; H Willcockson; A Esposito; N D'Onofrio; E Stein; T Li; T J Myers; H Ozkan; M L Balestrieri; V Ulici; R F Loeser; A Spagnoli
Journal:  Osteoarthritis Cartilage       Date:  2016-11-14       Impact factor: 6.576

Review 7.  Chemokine and chemotactic signals in dendritic cell migration.

Authors:  Laura Tiberio; Annalisa Del Prete; Tiziana Schioppa; Francesca Sozio; Daniela Bosisio; Silvano Sozzani
Journal:  Cell Mol Immunol       Date:  2018-03-21       Impact factor: 11.530

8.  Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys.

Authors:  S Dudal; K Subramanian; T Flandre; W S Law; P J Lowe; A Skerjanec; J-C Genin; M Duval; A Piequet; A Cordier; G Jarai; G Van Heeke; S Taplin; C Krantz; S Jones; A P Warren; F R Brennan; J Sims; P Lloyd
Journal:  MAbs       Date:  2015       Impact factor: 5.857

9.  Altered regulation of CXCR4 expression during aging contributes to increased CXCL12-dependent chemotactic migration of CD4(+) T cells.

Authors:  Stefania Cané; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Aging Cell       Date:  2012-06-04       Impact factor: 9.304

10.  Touch of chemokines.

Authors:  Xavier Blanchet; Marcella Langer; Christian Weber; Rory R Koenen; Philipp von Hundelshausen
Journal:  Front Immunol       Date:  2012-07-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.